Baker & Daniels in merger talks with Minneapolis firm
Indianapolis’ second-largest law firm could complete a deal with Minneapolis-based Faegre & Benson LLP in October. A need to get larger and to establish a regional presence is fueling the talks.
Home » Search
Search Results
4,410 results for '\"eli lilly\"'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
City chamber of commerce, Develop Indy might merge
Chamber Chairman John Neighbours said he "wouldn't rule out" combining the economic development groups.
Company news
Remember when physicians were highly suspicious of retail clinics in drugstores' stealing business from them? Well, now that docs are employed by hospitals, the clinics are being embraced. Indiana University Health announced last week that its physicians will serve as medical directors for 19 MinuteClinic locations, including 17 in the Indianapolis area, one in Bloomington and one in West Lafayette. The clinics are in CVS drugstores, as the company is a subsidiary of Rhode Island-based CVS Caremark Corp. Signs at the clinics will indicate the affiliation with IU Health. The organizations are linking their electronic medical record systems so that, with patient permission, records could be transferred easily from MinuteClinic to an IU Health physician, especially for patients needing more care than MinuteClinic can provide. However, MinuteClinic nurse practitioners will also send patient records to non-IU Health physicians if the patient wishes. The IU Health deal is the 11th hospital partnership signed by MinuteClinic across the country.
Eli Lilly and Co. could get an earlier-than-expected ruling from the U.S. Food and Drug Administration on its once-weekly version of Byetta. The FDA said it would render a decision on the new diabetes drug, called Bydureon, by Jan. 28, Lilly announced last week along with its partners, California-based Amylin Pharmaceuticals Inc. and Massachusetts-based Alkermes Inc. Bydureon would be a once-weekly injection of exenatide, the same compound in Byetta, which currently requires twice-daily injections. Byetta has proved effective at controlling blood sugar and even helping some patients lose weight. But concerns about it include causing pancreas problems and then competition from a similar once-daily drug called Victoza, launched by Denmark-based Novo Nordisk A/S. Lilly expected to receive approval for Bydureon in 2010, but the FDA required another study to test its effects on patients’ heart rhythms. When the new requirement was announced in October, Lilly said it expected approval of Bydureon to be delayed until mid-2012. Worldwide Byetta sales last year totaled $710 million.
A $10 million research endowment at the Eugene and Marilyn Glick Eye Institute has attracted seven new researchers to the Indiana University School of Medicine’s Ophthalmology Department. The department will move this month to a new building at 1160 W. Michigan St. The Glicks pledged a total of $30 million to the medical school—including $20 million that went toward the 80,000-square-foot building, which will house clinical research space, a full-service optical shop and the ophthalmology outpatient clinic. The clinic, which is moving from University Hospital, will double in size. The local philanthropists hoped their gift would vault IU into the top 10 for research and prevention of eye disease.
Lilly spent $1.9M lobbying feds in first quarter
Eli Lilly and Co. spent $1.9 million lobbying the federal government in the first quarter, focusing on the health care overhaul and overseas pricing reform, among many other issues.
City to seek more parking for Rolls-Royce’s move
The Capital Improvement Board will be charged with helping Rolls-Royce Corp. find up to an additional 500 parking spaces to accommodate the company’s move to a downtown office campus formerly occupied by Eli Lilly and Co.
Experts say options abound for former GM stamping plant
The 2-million-square-foot GM Indianapolis Metal Center, closed this year, sprawls over more than 100 acres on the west bank of the White River and enjoys some of the best views of the downtown skyline.
First step: Tear stamping plant down
Tear it down and clean it up was the message delivered by a former redevelopment director from South Bend as she spoke to representatives from cities who were about to lose their GM plants.
Sustainability, more new jobs key to GM site
Why not look at the entire neighborhood instead of just this old site?
This year’s metro area job losses deeper than in peer cities
As the national economy sputters, the Indianapolis area is losing jobs faster than its peers, falling to levels not seen since 2002.
Company news
Eli Lilly and Co. and its partner Germany-based Boehringer Ingelheim GmbH have won European market approval for linagliptin, a diabetes drug approved in the United States in May. The oral tablets will go by the name Trajenta in Europe, a slight alteration from the drug's U.S. trade name of Tradjenta. The drug helps patients with Type 2 diabetes reduce their blood sugar. The European Commission approved it for use on its own or with the standard diabetes pill metformin.
Indianapolis-based AMD Lasers LLC was acquired in June by Pennsylvania-based Dentsply International. AMD, founded in 2008 by Alan Miller, provides desktop laser technology to dentists at lower prices. It introduced its first product, called Picasso, in 2009.
Indiana University Health last week opened a kidney transplant telemedicine outreach clinic in Gary, one of seven it has around the state. The outreach clinic uses videoconferencing to conduct follow-up consultations with patients who have had a kidney transplant—so they don't have to travel to Indianapolis to see IU Health’s transplant surgeons face-to-face. The clinic is at Indiana University Northwest. IU Health’s other transplant outreach clinics, all established in the past three years, are in Avon, Carmel, Evansville, Fort Wayne, Merrillville and South Bend.
Commerce leader Roob leaving IEDC for private sector
The state’s Secretary of Commerce is stepping down to lead WoundVision LLC, an Indianapolis-based health care technology firm.
Mayoral foes see different paths to boost business
Both candidates for Indianapolis mayor are touting a host of ways to improve the city’s business climate. Incumbent Greg Ballard champions improving the city’s amenities. Challenger Melina Kennedy focuses on recruiting entrepreneurs to the city.
Butler center aims to make urban farming viable
Tim Carter, director of Butler University’s Center for Urban Ecology, is intent on making CUE a national leader in urban ecology by making the center’s research valuable on a broad scale.
FDA deal with drugmakers raises user fees 6 percent
Drugmakers including Eli Lilly an Co. have agreed with regulators on a 6-percent increase in review fees as part of reauthorizing the drug-approval process through fiscal 2017.
Who’s Who in Health Care and Benefits
Every business sector has influential players, whether they are in the public eye or wield their influence behind the scenes. This month, IBJ zeroes in on Health Care and Benefits.
People
Managed Health Services has hired Dana Moell as its director of member and provider services. Moell previously served as assistant director of alumni relations at DePauw University in Greencastle. She also served as a customer relations supervisor, manager and reservations general manager with ATA Airlines Inc. Managed Health Services, a subsidiary of St. Louis-based Centene Corp., is a health maintenance organization that has contracts with the Indiana Medicaid program and the Healthy Indiana Plan.
Indiana University Health appointed Eli Lilly and Co. executive Anne Nobles to its board of directors. Nobles is Lilly’s senior vice president for enterprise risk management and chief ethics and compliance officer.
FDA gets new report on Lilly diabetes drug
Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Monday that patients taking their potential once-weekly diabetes treatment, Bydureon, saw a significant improvement in cardiovascular risk factors.
Senate passes overhaul of patent system
The legislation would fundamentally alter the way patents are reviewed and mark the biggest change to U.S. patent law since at least 1952.
Lilly invests $30M in chronic-disease partnerships
Drugmaker Eli Lilly and Co. said Tuesday it will spend $30 million over five years to fight chronic illnesses like heart disease, diabetes, cancer and respiratory disease in developing countries.
Health regulatory leaders ready to flock to city
The top event for regulatory professionals in the health care industry is headed to Indianapolis next month. The annual conference of the Regulatory Affairs Professionals Society, or RAPS, is expected to draw thousands of members representing 120 companies and organizations.